Briefing: Clearing tumors in mice, Azalea Therapeutics advances dream of in vivo CAR-T therapy

Strategic angle: A mouse study shows CAR-T cells can be engineered in vivo with precise gene editing, a potential breakthrough that could cut costs and expand access.